PRELUDE CAPITAL MANAGEMENT, LLC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 256 filers reported holding 10X GENOMICS INC in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q1 2024$215,910
+6.9%
5,753
+315.1%
0.01%
+120.0%
Q3 2021$202,000
-65.7%
1,386
-53.9%
0.01%
-72.2%
Q2 2021$589,000
+37.6%
3,008
+27.1%
0.02%
+63.6%
Q1 2021$428,000
+12.6%
2,366
-11.8%
0.01%
+10.0%
Q4 2020$380,000
+39.2%
2,683
+22.6%
0.01%
-23.1%
Q3 2020$273,000
+221.2%
2,189
+130.4%
0.01%
+160.0%
Q2 2020$85,0009500.01%
Other shareholders
10X GENOMICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 708,528$29,226,780100.00%
Meritech Capital Associates V L.L.C. 494,236$20,387,2356.48%
Sands Capital Ventures, LLC 481,770$19,873,0135.88%
Decheng Capital Management III (Cayman), LLC 359,554$14,831,6034.95%
Iron Triangle Partners LP 666,945$27,511,4814.02%
Endurant Capital Management LP 71,044$2,930,5652.63%
Brown Capital Management 3,081,105$127,095,5811.95%
RTW INVESTMENTS, LP 1,519,956$62,698,1851.32%
Parametrica Management Ltd 15,300$631,1251.06%
Capital Impact Advisors, LLC 14,821$611,3661.02%
View complete list of 10X GENOMICS INC shareholders